Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1α transcription coactivator
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes mellitus, a disease with significant effects on the health and economy of Western societies, involves disturbances in both lipid and carbohydrate metabolism. In the insulin-resistant or diabetic state, the liver is unresponsive to the actions of insulin with regard to the suppression of glucose output but continues to produce large amounts of lipid, the latter mimicking the fed, insulin-replete condition. The disordered distribution of lipids contributes to the cardiovascular disease that is the greatest cause of mortality of type 2 diabetes mellitus. Yet the precise signal transduction pathways by which insulin regulates hepatic lipid synthesis and degradation remain largely unknown. Here we describe a mechanism by which insulin, through the intermediary protein kinase Akt2/protein kinase B (PKB)-beta, elicits the phosphorylation and inhibition of the transcriptional coactivator peroxisome proliferator-activated receptor-coactivator 1alpha (PGC-1alpha), a global regulator of hepatic metabolism during fasting. Phosphorylation prevents the recruitment of PGC-1alpha to the cognate promoters, impairing its ability to promote gluconeogenesis and fatty acid oxidation. These results define a mechanism by which insulin controls lipid catabolism in the liver and suggest a novel site for therapy in type 2 diabetes mellitus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AKT is a negative regulator of PGC-1α (Figure 3B).”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [68]
In the citing paper
“AKT phosphorylates and inhibits PGC-1α in response to insulin in liver [68] and activation of AKT causes a reduction in PGC-1α levels in heart [69].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [68]
Citations
Cites
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Mechanisms linking obesity with cardiovascular disease
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814
Metabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130
Puigserver, P., & Spiegelman, B. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0012 · Cited by 2,076
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Self-citationControl of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
Kohn, A. D., Summers, S. A., Birnbaum, M. J., & Roth, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31372 · Cited by 1,284
Self-citation
Cited by
Items 101–200 of 497
AKT Signaling in Physiology and Disease
Vasudevan, K. M., & Garraway, L. A. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_66 · Cited by 152
Cdc2-like Kinase 2 Is an Insulin-Regulated Suppressor of Hepatic Gluconeogenesis
Rodgers, J. T., Haas, W., Gygi, S. P., & Puigserver, P. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2009.11.006 · Cited by 129
“The SR domain on PGC1a is a well-documented regulatory region and has been shown to mediate PGC-1a’s insulin responsiveness via interaction with Foxo1 transcription factor and also contain an Akt phosphorylation site (Li et al., 2007; Puigserver et al., 2003).”
BackgroundInfluentialCui, A., Fan, H., Zhang, Y., Zhang, Y., Niu, D., Liu, S., Liu, Q., Ma, W., Shen, Z., Shen, L., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci66062 · Cited by 142
Cheng, K. K. Y., Iglesias, M. A., Lam, K. S. L., Wang, Y., Sweeney, G., Zhu, W., Vanhoutte, P. M., Kraegen, E. W., & Xu, A. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.03.013 · Cited by 133
“In addition, APPL1 possesses phosphoinositide-binding properties (Chial et al., 2008; Li et al., 2007a).”
BackgroundThe role of mitochondria-associated membranes in cellular homeostasis and diseases
Perrone, M., Caroccia, N., Genovese, I., Missiroli, S., Modesti, L., Pedriali, G., Vezzani, B., Vitto, V. A. M., Antenori, M., Lebiedzińska, M., et al. (2019) · International review of cytology · doi:10.1016/bs.ircmb.2019.11.002 · Cited by 141
“The two transcription factors FoxO1 and PGC1a positively regulate the expression of several genes involved in gluconeogenesis and fatty acid oxidation (Li et al., 2007).”
BackgroundThe potent roles of salt-inducible kinases (SIKs) in metabolic homeostasis and tumorigenesis
Sun, Z., Jiang, Q., Li, J., & Guo, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00265-w · Cited by 148
Keung, W., Ussher, J. R., Jaswal, J. S., Raubenheimer, M., Lam, V. H. M., Wagg, C. S., & Lopaschuk, G. D. (2013) · Diabetes · doi:10.2337/db12-0259 · Cited by 128
“However, whether transcriptional activity of PGC-1a is changed is unknown, because it has also been suggested that the activity of PGC-1a is dependent not only on its abundance but also on its posttranslational modification, including phosphorylation (49) and acetylation (50), which we have yet to assess.”
BackgroundSakamaki, J.-I., Daitoku, H., Ueno, K., Hagiwara, A., Yamagata, K., & Fukamizu, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015328108 · Cited by 130
Hormonal regulation of gluconeogenic gene transcription in the liver
Yabaluri, N., & Bashyam, M. D. (2010) · Journal of Biosciences · doi:10.1007/s12038-010-0052-0 · Cited by 128
“and phosphorylates and inactivates PGC-1α (Li et al. 2007).”
Hepatic transcriptional responses to fasting and feeding
Bideyan, L., Nagari, R., & Tontonoz, P. (2021) · Genes & Development · doi:10.1101/gad.348340.121 · Cited by 126
“The gluconeogenic functions of PGC-1α are inhibited in the fed state as a result of phosphorylation by S6 kinase, an effector of mTOR and AKT signaling downstream insulin (Li et al. 2007; Lustig et al. 2011).”
BackgroundPGC-1 coactivators in the cardiovascular system
Patten, I. S., & Arany, Z. P. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.09.007 · Cited by 134
Novel Small-Molecule PGC-1α Transcriptional Regulator With Beneficial Effects on Diabetic db/db Mice
Zhang, L., Zhou, H., Fu, Y., Li, Y., Wu, F., Gu, M., Wu, L., Xia, C.-M., Dong, T., Li, J.-Y., et al. (2013) · Diabetes · doi:10.2337/db12-0703 · Cited by 132
“It also was reported that increased insulin sensitivity might elicit the phosphorylation and inhibition of PGC-1a through kinase Akt2/protein kinase B-b (43).”
BackgroundMitochondrial quality control: Easy come, easy go
Stotland, A., & Gottlieb, R. A. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.12.041 · Cited by 118
Dietary Flavonoids in the Prevention of T2D: An Overview
Alkhalidy, H., Wang, Y., & Liu, D. (2018) · Nutrients · doi:10.3390/nu10040438 · Cited by 143
“The activation of Akt by insulin contributes to the control of hepatic glucose metabolism [99], reduction in hepatic glucose output by stimulating glycogen synthesis [100,101], and downregulation of PEPCK and G6Pase gene expression [102].”
BackgroundLontos, K., Wang, Y., Joshi, S. K., Frisch, A. T., Watson, M. J., Kumar, A., Menk, A. V., Wang, Y., Cumberland, R. L., Lohmueller, J. J., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006522 · Cited by 136
The Hormone Receptor GUCY2C Suppresses Intestinal Tumor Formation by Inhibiting AKT Signaling
Lin, J. E., Li, P., Snook, A. E., Schulz, S., Dasgupta, A., Hyslop, T., Gibbons, A. V., Marszlowicz, G., Pitari, G. M., & Waldman, S. A. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.064 · Cited by 127
The metabolic modulator PGC-1α in cancer.
Bost, F., & Kaminski, L. (2019) · Europe PMC (PubMed Central) · Cited by 169
Sestrins are evolutionarily conserved mediators of exercise benefits
Kim, M., Sujkowski, A., Namkoong, S., Gu, B., Cobb, T., Kim, B., Kowalsky, A. H., Cho, C.-S., Semple, I., Ro, S.-H., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13442-5 · Cited by 115
Bernard, K. F., Logsdon, N. J., Miguel, V., Benavides, G. A., Zhang, J., Carter, A. B., Darley-Usmar, V. M., & Thannickal, V. J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.752261 · Cited by 121
Separation of the gluconeogenic and mitochondrial functions of PGC-1α through S6 kinase
Lustig, Y., Ruas, J. L., Estall, J. L., Lo, J. C., Devarakonda, S., Laznik, D., Choi, J. H., Ono, H., Olsen, J. V., & Spiegelman, B. M. (2011) · Genes & Development · doi:10.1101/gad.2054711 · Cited by 116
“This pathway is largely independent on the type 1A PI 3-kinase and the AKT/PKB pathway (Nobukuni et al. 2005).”
BackgroundInfluentialFAM3A Activates PI3K p110α/Akt Signaling to Ameliorate Hepatic Gluconeogenesis and Lipogenesis
Wang, C., Chi, Y., Li, J., Miao, Y., Li, S., Su, W., Jia, S., Chen, Z., Du, S., Zhang, X., et al. (2014) · Hepatology · doi:10.1002/hep.26945 · Cited by 115
Taheri, R., Mokhtari, Y., Yousefi, A., & Bashash, D. (2024) · Cell Biology International · doi:10.1002/cbin.12189 · Cited by 126
“…factor FoxO1 makes a team with its co ‐ activator named PPAR γ coactivator 1 ‐ α (PGC ‐ 1 α ) to originally increase the expression of phosphoenol-pyruvate carboxykinase (PEPCK) and glucose ‐ 6 ‐ phosphatase genes — two necessary genes that participate in gluconeogenesis (Li et al., 2007).”
SUMOylation Attenuates the Function of PGC-1α
Rytinki, M. M., & Palvimo, J. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.038943 · Cited by 108
Liang, J., Liu, C., Qiao, A., Cui, Y., Zhang, H., Cui, A., Zhang, S., Yang, Y., Xiao, X., Chen, Y., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.10.024 · Cited by 119
Nuclear receptor coactivators: structural and functional biochemistry
Bulynko, Y. A., & O’Malley, B. W. (2011) · Biochemistry · doi:10.1021/bi101762x · Cited by 113
Monsalve, M., & Olmos, Y. (2011) · Current Drug Targets · doi:10.2174/138945011796150307 · Cited by 124
“The PGC-1α-FOXO1-mediated induction of the ALAS-1 promoter is repressed by insulin, probably through the activation of AKT, which phosphorylates FOXO1 disrupting its binding to PGC-1α.”
BackgroundInfluentialKaarniranta, K., Kajdanek, J., Morawiec, J., Pawlowska, E., & Blasiak, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082317 · Cited by 112
FGF15/FGFR4 Integrates Growth Factor Signaling with Hepatic Bile Acid Metabolism and Insulin Action
Shin, D.-J., & Osborne, T. F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808747200 · Cited by 111
Liu, H.-Y., Hong, T., Wen, G.-B., Han, J., Zuo, D., Liu, Z., & Cao, W. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00374.2009 · Cited by 115
PGC-1 Proteins and Heart Failure
Riehle, C., & Abel, E. D. (2012) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.07.003 · Cited by 119
Zhang, L., Zhang, W., Li, Z., Lin, S., Zheng, T., Hao, B., Hou, Y., Zhang, Y., Wang, K., Qin, C., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02439-6 · Cited by 118
“Phosphorylation of PGC1-αby Akt will largely inhibit its transcriptional activity [128, 129].”
BackgroundPGC-1 Coactivators: Shepherding the Mitochondrial Biogenesis of Tumors
Luo, C., Widlund, H. R., & Puigserver, P. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.09.006 · Cited by 116
The biology of PGC-1α and its therapeutic potential
Handschin, C. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.03.006 · Cited by 108
Jang, H., Lee, G. Y., Selby, C. P., Lee, G., Jeon, Y. G., Lee, J. H., Cheng, K. K. Y., Titchenell, P., Birnbaum, M. J., Xu, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms12180 · Cited by 99
Self-citationMinireview: The PGC-1 Coactivator Networks: Chromatin-Remodeling and Mitochondrial Energy Metabolism
Lin, J. D. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0344 · Cited by 103
“Interestingly, the function of PGC-1 in this context is negatively regulated by insulin signaling pathway and requires leucine-rich protein 130 kDa (LRP130), a binding partner for PGC-1 (52, 53).”
Akt isoforms and glucose homeostasis – the leptin connection
Hay, N. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.09.003 · Cited by 101
Multi-modulation of nuclear receptor coactivators through posttranslational modifications
Han, S. J., Lonard, D. M., & O’Malley, B. W. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.10.001 · Cited by 96
Gurd, B. J., Yoshida, Y., McFarlan, J. T., Holloway, G. P., Moyes, C. D., Heigenhauser, G. J. F., Spriet, L., & Bonen, A. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00417.2010 · Cited by 94
Mitochondrial regulator PGC-1a—Modulating the modulator
Miller, K. N., Clark, J. P., & Anderson, R. M. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.02.002 · Cited by 111
“Phosphorylation of PGC-1a can also be inhibitory, as is the case with AKT [35] and CLK2 [36], which phosphorylate PGC-1a on multiple sites within the SR domain, blocking interaction between PGC-1a and MED1 of the mediator complex.”
BackgroundEmerging role of AMP-activated protein kinase in endocrine control of metabolism in the liver
Hasenour, C. M., Berglund, E. D., & Wasserman, D. H. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.018 · Cited by 99
The Protein Level of PGC-1α, a Key Metabolic Regulator, Is Controlled by NADH-NQO1
Adamovich, Y., Shlomai, A., Tsvetkov, P., Umansky, K. B., Reuven, N., Estall, J. L., Spiegelman, B. M., & Shaul, Y. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01672-12 · Cited by 95
“The insulin signaling pathway has been shown to negatively regulate PGC-1 induction (70, 71).”
BackgroundXiong, S., Patrushev, N., Forouzandeh, F., Hilenski, L., & Alexander, R. W. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.047 · Cited by 96
“Enforced expression of a PGC-1α constitutive active form (PGC-1α-CA: PGC-1α-S570A) (Li et al., 2007; Xiong et al., 2013; Xiong et al., 2010) or TERT reversed the established senescence phenotype (Figure 1K) and restored telomerase activities (Figure 1L) and telomere length (Figures 1M and S1J).”
BackgroundQiao, L., Kinney, B., Yoo, H. S., Lee, B., Schaack, J., & Shao, J. (2012) · Diabetes · doi:10.2337/db11-1475 · Cited by 94
Regulation of Hypoxia-Inducible Genes by PGC-1α
Shoag, J., & Arany, Z. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.181636 · Cited by 96
Liu, H.-Y., Cao, S. Y., Hong, T., Han, J., Liu, Z., & Cao, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016675 · Cited by 91
Alaaeldin, R., Abdel-Rahman, I. A. M., Hassan, H. A., Youssef, N., Allam, A. E., Abdelwahab, S. F., Zhao, Q.-L., & Fathy, M. (2021) · Molecules · doi:10.3390/molecules26247629 · Cited by 92
“Akt primarily phosphorylates and inhibits FoxO1 proteins with further inhibition on gluconeogenesis pathway [45].”
BackgroundSignal transductions and nonalcoholic fatty liver: a mini-review.
Zeng, L., Tang, W. J., Yin, J. J., & Zhou, B. J. (2014) · Europe PMC (PubMed Central) · Cited by 105
Opposing Roles for ATF2 and c-Fos in c-Jun-Mediated Neuronal Apoptosis
Yuan, Z., Gong, S., Luo, J., Zheng, Z., Song, B., Ma, S., Guo, J., Hu, C., Thiel, G., Vinson, C., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01344-08 · Cited by 92
“amplified and purified as described previously (29, 44).”
MethodThe Fox Genes in the Liver: From Organogenesis to Functional Integration
Lay, J. E. L., & Kaestner, K. H. (2010) · Physiological Reviews · doi:10.1152/physrev.00018.2009 · Cited by 104
“Binding of insulin to its receptor on the cell surface initiates a series of phosphorylation events involving the sequential recruitment of IRS proteins, induction of phosphoinositol (PI)3-kinase, and finally the activation of AKT, a kinase which can, in turn, directly modify regulatory molecules such as transcription…”
BackgroundNie, Y., Sato, Y., Wang, C., Yue, F., Kuang, S., & Gavin, T. P. (2016) · The FASEB Journal · doi:10.1096/fj.201600529r · Cited by 98
“In hepatocytes, FoxO1 directly promotes the transcription of Pgc1a (34), whereas insulin inhibits Pgc1a-mediated gluconeogenesis via suppression of FoxO1 by Akt (35).”
BackgroundCardioprotection in the aging, diabetic heart: the loss of protective Akt signalling
Whittington, H. J., Harding, I., Stephenson, C., Bell, R., Hausenloy, D. J., Mocanu, M. M., & Yellon, D. M. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt140 · Cited by 96
“Another detrimental effect of chronic Akt phosphorylation may be the indirect down-regulation of the transcriptional co-activator PGC-1a.(35) PGC-1a is a transcriptional co-activator and a key regulator of energy metabolism and mitochondrial biogenesis(36) and also regulates ROS detoxification systems.”
BackgroundAn, J. H., Yang, J., Ahn, B. Y., Cho, S. W., Jung, J. Y., Cho, H. Y., Cho, Y. M., Kim, S. W., Park, K. S., Kim, S. Y., et al. (2010) · Bone · doi:10.1016/j.bone.2010.04.593 · Cited by 89
“Different signaling cascades have been shown to regulation of PGC-1α expression including CREB [49], Akt[50,51], and AMPK[52,53].”
BackgroundChang, J. S., Huypens, P., Zhang, Y., Black, C., Kralli, A., & Gettys, T. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.083121 · Cited by 84
PGC-1s in the Spotlight with Parkinson’s Disease
Piccinin, E., Sardanelli, A. M., Seibel, P., Moschetta, A., Cocco, T., & Villani, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073487 · Cited by 87
“Differently, protein kinase B (AKT) produces a more unstable PGC-1α protein, with consequently decreased expression of target genes [122].”
BackgroundCao, X., Yang, F., Shi, T., Yuan, M., Xin, Z., Xie, R., Li, S., Li, H., & Yang, J.-K. (2016) · Scientific Reports · doi:10.1038/srep21592 · Cited by 84
“Activation of Akt represses lipogenesis and prevents excessive lipid deposition in the liver [42] [43] [44] .”
BackgroundRen, Z., Xie, Z., Cao, D., Gong, M., Yang, L., Zhou, Z., & Ou, Y. (2018) · Food & Function · doi:10.1039/c8fo00257f · Cited by 89
Xiong, S., Salazar, G., San Martin, A., Ahmad, M., Patrushev, N., Hilenski, L., Nazarewicz, R. R., Ma, M., Ushio-Fukai, M., & Alexander, R. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.065235 · Cited by 85
Metabolic roles of PGC-1α and its implications for type 2 diabetes
Besseiche, A., Riveline, J., Gautier, J., Bréant, B., & Blondeau, B. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.02.002 · Cited by 97
“[19] Li X, Monks B, Ge Q, Birnbaum MJ.”
BackgroundGCN5 acetyltransferase in cellular energetic and metabolic processes
Mutlu, B., & Puigserver, P. (2020) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2020.194626 · Cited by 88
Dissecting the role of insulin resistance in the metabolic syndrome
Haas, J. T., & Biddinger, S. B. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832b2024 · Cited by 80
Chung, H. W., Lim, J. H., Kim, M. Y., Shin, S. J., Chung, S., Choi, B. S., Kim, H. W., Kim, Y.-S., Park, C. W., & Chang, Y. S. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr613 · Cited by 82
Rosenkranz, S. C., Shaposhnykov, A., Träger, S., Engler, J. B., Witte, M. E., Roth, V., Vieira, V., Paauw, N. J., Bauer, S., Schwencke-Westphal, C., et al. (2021) · eLife · doi:10.7554/elife.61798 · Cited by 86
Xiong, S., Salazar, G., Patrushev, N., Ma, M., Forouzandeh, F., Hilenski, L., & Alexander, R. W. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.301019 · Cited by 79
“Phosphorylation of PGC-1α Ser570 by insulin was identified originally as an inhibitory signal for PGC-1α coactivation of genes involved in gluconeogenesis and fatty acid oxidation.(42) Ser570 phosphorylation of PGC-1α by Ang II triggers enhanced GCN5 recruitment to and lysine acetylation of PGC-1α in vitro(16) and in…”
BackgroundMitochondrial immune regulation and anti-tumor immunotherapy strategies targeting mitochondria
Bai, R., & Cui, J. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216223 · Cited by 90
Transcriptional Regulation of Hepatic Fatty Acid Metabolism
Guillou, H., Martin, P. G. P., & Pineau, T. (2008) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4020-8831-5_1 · Cited by 91
“PGC1-a has been shown to be a downstream target for PI3K/PKB (Li et al., 2007).”
BackgroundMoreno, M., Lombardi, A., Silvestri, E., Senese, R., Cioffi, F., Goglia, F., Lanni, A., & de Lange, P. (2010) · PPAR Research · doi:10.1155/2010/435689 · Cited by 87
“Activation of PGC-1α by phosphorylation through p38 MAPK and AMPK occurs in muscle [74, 75] whereas, in contrast, phosphorylation of PGC-1α in the liver by Akt/protein kinase B (Akt/PKB, which is a central kinase in the insulin-signaling cascade) leads to decreased stability and activity (see [76]; Figure 1).”
BackgroundA time to reap, a time to sow: Mitophagy and biogenesis in cardiac pathophysiology
Andres, A. M., Stotland, A., Queliconi, B. B., & Gottlieb, R. A. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.10.003 · Cited by 78
“Conversely, insulin inhibits the activity of PGC-1α through Akt, directly through phosphorylation of the serine-570 residue on PGC-1α, and indirectly through phosphorylation of the Clk2 kinase which in turn phosphorylates the C-terminal serine and threonine-rich regions of PGC-1α, thereby decreasing its co-transcripti…”
BackgroundPapa, S., Rasmo, D. D., Technikova-Dobrova, Z., Panelli, D., Signorile, A., Scacco, S., Petruzzella, V., Papa, F., Palmisano, G., Gnoni, A., et al. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.09.019 · Cited by 89
“deacetylation by SIRT1 [83], phosphorylation by AMPK [84] and inhibited by phosphorylation by the insulin activated AKT [85].”
BackgroundWeighing In on mTOR Complex 2 Signaling: The Expanding Role in Cell Metabolism
Luo, Y., Xu, W., Li, G., & Cui, W. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7838647 · Cited by 75
“In addition, mTORC2-mediated Akt activation is also responsible for the phosphorylation and inhibition of PGC1α (peroxisome proliferatoractivated receptor gamma coactivator 1-alpha), a transcription coactivator involved in activating gluconeogenic gene expression [69].”
BackgroundLiu, X., Li, D., Pi, W., Wang, B., Xu, S., Yu, L., Yao, L., Sun, Z., Jiang, J., & Mi, Y. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109379 · Cited by 90
Sildenafil for the Treatment of Alzheimer’s Disease: A Systematic Review
Sanders, O. (2020) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-200166 · Cited by 77
Xu, E., Schwab, M. G., & Marette, A. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9282-4 · Cited by 86
Borniquel, S., García-Quintáns, N., Valle, I., Olmos, Y., Wild, B., Martínez-Granero, F., Soria, E., Lamas, S., & Monsalve, M. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00175-10 · Cited by 73
Posttranslational regulation of PGC‐1α and its implication in cancer metabolism
Luo, X., Liao, C., Quan, J., Cheng, C., Zhao, X., Bode, A. M., & Cao, Y. (2019) · International Journal of Cancer · doi:10.1002/ijc.32253 · Cited by 78
Santi, S. A., & Lee, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014614 · Cited by 77
Marinho, R., Ropelle, E. R., Cintra, D. E., de Souza, C. T., da Silva, A. S. R., Bertoli, F. C., Colantonio, E., D’Almeida, V., & Pauli, J. R. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.23037 · Cited by 83
Fang, P., Sun, Y., Gu, X., Shi, M., Bo, P., Zhang, Z., & Bu, L. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.153074 · Cited by 74
Rodríguez-Hernández, M. A., de la Cruz‐Ojeda, P., López-Grueso, M. J., Navarro‐Villarán, E., Requejo-Aguilar, R., Castejón‐Vega, B., Negrete, M., Gallego, P., Vega-Ochoa, Á., Víctor, V. M., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101510 · Cited by 77
CITED2 links hormonal signaling to PGC-1α acetylation in the regulation of gluconeogenesis
Sakai, M., Matsumoto, M., Tujimura, T., Yongheng, C., Noguchi, T., Inagaki, K., Inoue, H., Hosooka, T., Takazawa, K., Kido, Y., et al. (2012) · Nature Medicine · doi:10.1038/nm.2691 · Cited by 77
The Epidemiology and Molecular Mechanisms Linking Obesity, Diabetes, and Cancer
Ferguson, R. D., Gallagher, E. J., Scheinman, E. J., Damouni, R., & LeRoith, D. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-416673-8.00010-1 · Cited by 84
PGC‐1α, a potential therapeutic target against kidney aging
Lee, G., Uddin, M. J., Kim, Y., Ko, M., Yu, I., & Ha, H. (2019) · Aging Cell · doi:10.1111/acel.12994 · Cited by 69
Liver Med23 ablation improves glucose and lipid metabolism through modulating FOXO1 activity
Chu, Y., Rosso, L. A. G., Huang, P., Wang, Z., Xu, Y., Xiao, Y., Bao, M., Yan, J., Song, H., & Wang, G. (2014) · Cell Research · doi:10.1038/cr.2014.120 · Cited by 74
Regulating microRNA expression: at the heart of diabetes mellitus and the mitochondrion
Hathaway, Q. A., Pinti, M. V., Durr, A. J., Waris, S. A., Shepherd, D. L., & Hollander, J. M. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00520.2017 · Cited by 69
“PPAR- coactivator (PGC)1 , an essential coactivator of PPAR- and inducer of medium-chain acyl-CoA dehydrogenase, has been found to be directly regulated by the miRNA-29 family (miRNA-29a-c) (86, 88).”
BackgroundChanges in Components of Energy Regulation in Mouse Cortex with Increases in Wakefulness
Nikonova, E. V., Naidoo, N., Zhang, L., Romer, M., Cater, J. R., Scharf, M. T., Galante, R. J., & Pack, A. I. (2010) · Sleep · doi:10.1093/sleep/33.7.889 · Cited by 67
Ribeiro, R. A., Santos-Silva, J. C., Vettorazzi, J. F., Cotrim, B. B., Mobiolli, D. D. M., Boschero, A. C., & Carneiro, E. M. (2012) · Amino Acids · doi:10.1007/s00726-012-1263-5 · Cited by 68
“In addition, Akt inactivates transcription factors such as Foxo1 (forkhead transcription factors) and PGC-1a (peroxisome proliferator-activated receptor-coactivator 1c) that regulate the expression of genes involved in gluconeogenesis and fatty acid oxidation (Whiteman et al. 2002; Li et al. 2007).”
BackgroundKachaylo, E., Tschuor, C., Calo, N., Borgeaud, N., Ungethüm, U., Limani, P., Piguet, A., Dufour, J., Foti, M., Graf, R., et al. (2017) · Hepatology · doi:10.1002/hep.29226 · Cited by 69
“Although AKT’s role in fostering hepatic lipid accumulation is established,((37)) AKT can promote lipid catabolism in situations associated with energy deprivation such as exercise or fasting.”
BackgroundSestrins in Physiological Stress Responses
Kim, M., Kowalsky, A. H., & Lee, J. H. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-031620-092317 · Cited by 71
MAPK phosphatase-1 facilitates the loss of oxidative myofibers associated with obesity in mice
Roth, R. J., Le, A. M., Zhang, L., Kahn, M., Samuel, V. T., Shulman, G. I., & Bennett, A. M. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39054 · Cited by 65
The Shc locus regulates insulin signaling and adiposity in mammals
Tomilov, A. A., Ramsey, J. J., Hagopian, K., Giorgio, M., Kim, K. M., Lam, A., Migliaccio, E., Lloyd, K. C., Berniakovich, I., Prolla, T. A., et al. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2010.00641.x · Cited by 64
“Insulin-inhibitable glucose release was assayed similarly as described (Yoon et al., 2001; Li et al., 2007).”
MethodLi, J., Chi, Y., Wang, C., Wu, J., Yang, H., Zhang, D., Zhu, Y., Wang, N., Yang, J., & Guan, Y. (2011) · Hepatology · doi:10.1002/hep.24295 · Cited by 63
Hager, L., Li, L., Pun, H., Liu, L., Hossain, M. A., Maguire, G. F., Naples, M., Baker, C., Magomedova, L., Tam, J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.340919 · Cited by 61
“Akt also performs two other major functions in the insulin pathway – activation of protein kinase C (PKC) to promote glucose uptake via GLUT4 transporters and also activation of glycogen synthase to store the glucose as glycogen [96, 97].”
BackgroundInactivation of glycogen synthase kinase-3β (GSK-3β) enhances skeletal muscle oxidative metabolism
Theeuwes, W. F., Gosker, H. R., LANGEN, R. C. J., Verhees, K. J. P., Pansters, N., Schols, A. M. W. J., & Remels, A. H. V. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.09.018 · Cited by 67
Grabacka, M., Pierzchalska, M., & Reiss, K. (2013) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201011314030009 · Cited by 58
Leptin Deficiency and Beta-Cell Dysfunction Underlie Type 2 Diabetes in Compound Akt Knockout Mice
Chen, W. S., Peng, X.-D., Wang, Y., Xu, P.-Z., Chen, M.-L., Yongmei, L., Jeon, S., Coleman, K. G., Haschek, W. M., Bass, J. T., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01792-08 · Cited by 61
“Recently, it was shown that Akt can also phosphorylate and inactivate PGC1 (24), which is a coactivator for transcription factors that affect gluconeogenesis, such as FOXO1, HNF4 , and PPAR (25).”
BackgroundPremaratna, S. D., Manickam, E., Begg, D. P., Rayment, D. J., Hafandi, A., Jois, M., Cameron‐Smith, D., & Weisinger, R. S. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.95 · Cited by 60
Shin, H., Park, Y., Kim, S.-U., Moon, H., Park, D., Han, Y., Lee, C., Lee, D., Song, I.-S., Lee, D. H., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.259978 · Cited by 62
Handschin, C. (2010) · Journal of Receptors and Signal Transduction · doi:10.3109/10799891003641074 · Cited by 56
Myles, S., Lea, R. A., Ohashi, J., Chambers, G. K., Weiss, J., Hardouin, E. A., Engelken, J., Macartney-Coxson, D. P., Eccles, D., Naka, I., et al. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-10 · Cited by 69
“PPARGC1A plays a pivotal role in insulin signaling, mitochondrial regulation and adaptive thermogenesis [15-17] and is a reasonable thrifty gene candidate as it integrates metabolic pathways that support mammalian survival during prolonged starvation or hibernation [18,19].”
BackgroundJelenik, T., Séquaris, G., Kaul, K., Ouwens, D. M., Phielix, E., Kotzka, J., Knebel, B., Weiß, J., Reinbeck, A. L., Janke, L., et al. (2014) · Diabetes · doi:10.2337/db13-1794 · Cited by 56
Inhibition of protein arginine methyltransferase 5 enhances hepatic mitochondrial biogenesis
Huang, L., Liu, J., Zhang, X.-O., Sibley, K. J., Najjar, S. M., Lee, M., & Wu, Q. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002377 · Cited by 61
“AKT was found to phosphorylate and inhibit PGC-1 (63).”
Background
Metadata
- Authors
- Li, X., Monks, B., Ge, Q., & Birnbaum, M. J.
- Affiliations
- Howard Hughes Medical Institute (US)
- Cell Signaling Technology (United States) (US)
- Corresponding author
- Birnbaum, Morris J.
- Venue
- Nature
- Published
- 2007-06
- Volume
- 447
- Issue
- 7147
- Pages
- 1012-1016
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1982810858
- Cited by
- 487
- References
- 29
- Citations by year
- 2026: 6 · 2025: 19 · 2024: 25 · 2023: 19 · 2022: 16 · 2021: 26 · 2020: 33 · 2019: 21 · 2018: 27 · 2017: 24 · 2016: 15 · 2015: 24 · 2014: 26 · 2013: 24 · 2012: 32
- FWCI
- 13.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- PGC-1α, insulin signaling, hepatic metabolism, type 2 diabetes, insulin resistance, gluconeogenesis, fatty acid oxidation, cardiovascular disease
- MeSH terms
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Animals, Chromatin, Diabetes Mellitus, Type 2, Gene Expression Regulation, Glucose, Liver, Phosphorylation, Phosphoserine, Transcription Factors, Trans-Activators, Down-Regulation, Cell Line, Tumor, Proto-Oncogene Proteins c-akt, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.